medcitynews.comMedCity News - Healthcare technology news, life science current events

Menu Search Home Engagement Convergence Investing & Startups AI Precision Medicine Digital Health Special Reports Events MedCitizens About Us Advertising Contact us Send Tips Advertising About Twitter Facebook RSS Subscribe via email X Close Signup Modal MedCity >> Inbox Get the latest industry news first when you subscribe to our daily newsletter. We will never sell or share your information without your consent. See our privacy policy . Send Tips Advertising About Twitter Facebook RSS Subscribe via email MedCity News Engagement Investing & Startups AI Precision Medicine Digital Health Events Special Reports MedCitizens Careers Healthcare startups: Apply now to participate in the 2020 INVEST Pitch Perfect startup competition Join investors, healthcare execs and startups at INVEST Chicago 2020. Save 40% now. BioPharma , Legal These drug patents are expected to expire in 2020 By Alaric DeArment According to a report, drugmakers are expected to lose $17 billion in worldwide sales due to patent expirations this year. Two reports list 18 drugs as losing patent protection or exclusivity, though not all drugs listed here will necessarily face generic or biosimilar competition in 2020. Share / at 10:00 AM Hospitals The role of real estate in the future of healthcare By Richard Taylor The evolution of healthcare away from traditional hospital campuses is gaining momentum as new technology has become a key driver in the shift to outpatient care. Share / at 3:54 PM Startups One Medical raises $245M in IPO By Elise Reuter One Medical began trading on Nasdaq on Friday. The primary care startup priced its IPO at $14 per share, for roughly $245 million. Share / at 3:27 PM Startups StartUPDATES: New developments with healthcare startups By MedCity News Read about new developments at innovative healthcare startups such as Bright.MD, GYANT, and more. Share / at 7:55 AM SYN Sony gets FDA clearance for OR integration system By Elise Reuter Sony received 510k clearance for its OR integration system, NUCLeUS, which allows surgeons to connect numerous instruments, screens and other applications to one platform. Sony has been selling the technology in Europe, and can now market and sell it in the U.S. Share / Jan 30, 2020 at 5:29 PM Startups , Artificial Intelligence , Health Tech Cleveland Clinic expands partnership with telemedicine startup GYANT By Elise Reuter Telemedicine startup GYANT will work with the Cleveland Clinic to improve communication between providers and patients after they are discharged from the hospital. The company uses its chat interface to make it easier for patients to chat with their care team after discharge, and will be expanded to Cleveland Clinic’s Women’s Health Institute. Share / Jan 30, 2020 at 2:57 PM Promoted The digital transformation of medical Multiply the impact of medical affairs without compromising authenticity eyeforpharma MedCity Influencers , Artificial Intelligence Transforming healthcare practices and patient care in the digital era By Nitin Kumar While digitizing records has been a focal point for industry players in the past, investment in next-gen technology will become bolder and more widespread. Share / Jan 30, 2020 at 2:15 PM BioPharma Flagship Pioneering launches fertility-focused Ohana Biosciences By Alaric DeArment The company’s approach shifts the focus of fertility from biology of the egg to that of sperm. It aims to develop products to improve fertility and also create a contraceptive for men. Share / Jan 30, 2020 at 2:06 PM Startups , BioPharma Mammoth Biosciences raises $45M Series B round for CRISPR diagnostics, therapeutics development By Alaric DeArment The latest round of funding, led by Chinese investors, brings the total amount of money raised by the company, co-founded by CRISPR pioneer Jennifer Doudna, to more than $70 million. Share / Jan 30, 2020 at 12:00 PM Artificial Intelligence , Health Tech Microsoft commits $40M to AI for Health initiative By Elise Reuter Microsoft’s latest effort will provide resources to researchers and nonprofits working to improve healthcare. The company is primarily focusing on three areas: medical research, global health, and access to care. Share / Jan 29, 2020 at 7:01 PM —ADVERTISEMENT— Promoted Premier annual pediatric medical device competition now accepting submissions for cardiovascular, orthopedic and NICU innovations Apply to Pitch in the 2020 Pediatric Device Innovation Symposium Children's National Hospital Join Us at MedCity INVEST 2020 MedCity INVEST , held April 21-22, 2020 in Chicago, is the premier national healthcare investing conference based in the Midwest, uniting active investors with corporate business development executives to facilitate investment opportunities with the most promising healthcare startups. Reserve your place.>> GOT NEWS? SEND US A TIP MedCity >> Inbox Get the latest industry news first when you subscribe to our daily newsletter. We will never sell or share your information without your consent. See our privacy policy . Sections Hospitals Insightec wants to usher in a new era of incisionless surgery BioPharma As precision medicine grows, so does the importance of clinical trial diversity Health IT Nuance’s AI makeover to clinical documentation takes exam room to the future BioPharma Makers of novel cell/gene therapy say off-the-shelf approach only way to solve pricing woes By Arundhati Parmar In a recent interview, executives from two early-stage biopharma companies said that off-the-shelf approach is the only way to drive down the cost of novel cell and gene therapies like CAR-T. Share / Jan 29, 2020 at 5:14 PM Employee Benefits , Payers Anthem sees Medicare Advantage membership grow by 20 percent By Elise Reuter Anthem Inc. saw Medicare Advantage enrollment increase more than 20% year-over-year. The company now has a total of 1.2 million members enrolled in Medicare Advantage plans, and expects to add another 150,000 to 200,000 members next year. Share / Jan 29, 2020 at 4:33 PM BioPharma Bristol-Myers Squibb holds lead among myeloma drugs with popular antigen target, analyst writes By Alaric DeArment A Cannacord Genuity analyst pointed to BMS’ large pipeline of BCMA-targeting therapies and advanced data, particularly for its CAR-T. However, GlaxoSmithKline has also asserted its anti-BCMA drug could be first past the FDA finish line. But does it matter? Share / Jan 29, 2020 at 1:30 PM Medical Devices , Artificial Intelligence Eko wins FDA clearance for heart murmur, Afib algorithm By Joel Berg The algorithm is not designed to replace consumer-facing devices. But while most smart watches track electrical signals from the heart, Eko focuses on sound as a means to improve the work of front-line clinicians. Share / Jan 29, 2020 at 1:16 PM Promoted Attention healthcare startups: Time to apply to MedCity INVEST Pitch Perfect Unlike most pitching events, the INVEST Pitch Perfect competition on April 21-22, 2020 in Chicago spans health IT and life science sectors, including biopharma, diagnostics, and medical devices. MedCity News BioPharma Trovagene tries roundabout approach to colorectal cancer with ‘undruggable’ mutation By Alaric DeArment Although they’re still early, the company presented Phase Ib/II study data showing its PLK1 inhibitor, onvasertib, was able to produce responses in KRAS-mutated metastatic CRC, through a property known as synthetic lethality. KRAS-specific drugs have shown low efficacy in mCRC. Share / Jan 29, 2020 at 10:47 AM Promoted Digital Health: Advancing Innovation Through Technology and Strategic Partnerships Discover the Current Realities and Future Trends EBD Group Health IT , LOL MedCity’s weekly cartoon: Whither interoperability? By MedCity News Given all the news about interoperability, we couldn’t resist. Share / Jan 29, 2020 at 12:23 AM Health IT , Legal Practice Fusion allegedly weaponized EHRs in kickback scheme By Elise Reuter Practice Fusion will pay $145 million to resolve cr...